SANJIVIN

Sanjivani Paranteral Ltd (NSE: SANJIVIN) Q3 2026 Earnings Call dated Feb. 16, 2026 Corporate Participants: Srivardhan Khemka — Executive Director…

Sanjivani Parenteral Limited (BSE: 531569), a manufacturer of parenteral and oral solid dosage formulations across therapeutic areas including CNS, cardiovascular,…